Premium
Rituximab in Pediatric Renal Transplantation: A Treatment for Allograft Rejection with B‐Cell Infiltrates?
Author(s) -
Zand M. S.
Publication year - 2008
Publication title -
american journal of transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.89
H-Index - 188
eISSN - 1600-6143
pISSN - 1600-6135
DOI - 10.1111/j.1600-6143.2008.02454.x
Subject(s) - medicine , rituximab , transplantation , cd20 , clinical trial , biopsy , gastroenterology , immunology , antibody
A recent pediatric pilot of rituximab for treatment of renal allograft rejections with B cell infiltrates is intriguing, but much more data and adequately powered clinical trials are needed to determine whether therapy is efficacious. See also article by Zarkhin et al in this issue on page 2607.